(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

3PBIOVΙAΝ

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

3PBIOVΙAΝ

ST13

US500000079401041

Class

40, 42

Filing

79401041

Registration

7805744

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

04/03/2026

Trademark type

Combined

Nice classes

40, 42

Filing date

06/24/2024

Registration date

05/27/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/27/2025

Last transaction

04/03/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

5

Owner type

99

Owner location

ES

Examiner

CHOE, JULIE H

Law office

N80

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of the stylized wording "3PBIOVIAN" in a gradient shading consisting of pink on the left to blue on the right, on a white background.

Holders and representatives

Holders

3P BIOPHARMACEUTICALS, S.L.

Representatives

Elizabeth Lee D'Amore LUCAS & MERCANTI, LLP

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Custom manufacture of medicinescustom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacture of dietary supplements for humans; transformation of biopharmaceutical materials for third partiescustom manufacture of biopharmaceuticals

Class 42

Research and development of pharmaceutical products in connection with biotechnology; research in the field of gene editing technology; scientific testing services in the field of pharmaceutical products; clinical studies for pharmaceutical productsscientific studies in the field of pharmaceutical products; biotechnology testingscientific testing in the field of biotechnology; scientific and medical research information regarding pharmaceutical products and clinical trials; medical research laboratory services; biological research laboratory services; biological researchclinical research in the field of pharmaceuticalmedical research

Publications

History of USPTO decisions and trademark events.

29 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

02/26/2026

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

01/13/2026

XXCR

GENERIC MADRID TRANSACTION CREATED

01/13/2026

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

01/08/2026

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

12/24/2025

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

12/24/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/13/2025

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

12/13/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/13/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/13/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/27/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

05/27/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

05/27/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/08/2025

PUBO

PUBLISHED FOR OPPOSITION

04/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

04/02/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

03/12/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

03/12/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

03/12/2025

RFNT

REFUSAL PROCESSED BY IB

02/22/2025

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

01/31/2025

RFRR

REFUSAL PROCESSED BY MPU

01/31/2025

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

12/28/2024

CNRT

NON-FINAL ACTION WRITTEN

12/27/2024

DOCK

ASSIGNED TO EXAMINER

12/22/2024

MAFR

APPLICATION FILING RECEIPT MAILED

07/30/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/30/2024

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

07/26/2024

Continuous trademark protection

Get notified about every new filing that threatens 3PBIOVΙAΝ or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.